401 related articles for article (PubMed ID: 15368324)
21. The prognostic value of vascular endothelial growth factors (VEGFs)-A and -B and their receptor, VEGFR-1, in invasive breast carcinoma.
Mylona E; Alexandrou P; Giannopoulou I; Liapis G; Sofia M; Keramopoulos A; Nakopoulou L
Gynecol Oncol; 2007 Mar; 104(3):557-63. PubMed ID: 17150246
[TBL] [Abstract][Full Text] [Related]
22. Correlation between lymph node metastasis and the expression of VEGF-C, VEGF-D and VEGFR-3 in T1 lung adenocarcinoma.
Maekawa S; Iwasaki A; Shirakusa T; Enatsu S; Kawakami T; Kuroki M; Kuroki M
Anticancer Res; 2007; 27(6A):3735-41. PubMed ID: 17970036
[TBL] [Abstract][Full Text] [Related]
23. Vascular endothelial growth factor-C expression in bladder transitional cell cancer and its relationship to lymph node metastasis.
Zu X; Tang Z; Li Y; Gao N; Ding J; Qi L
BJU Int; 2006 Nov; 98(5):1090-3. PubMed ID: 17034609
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of vascular endothelial growth factor D in breast carcinoma with long-term follow-up.
Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
Clin Cancer Res; 2003 Feb; 9(2):716-21. PubMed ID: 12576440
[TBL] [Abstract][Full Text] [Related]
25. Vascular endothelial growth factor D and intratumoral lymphatics as independent prognostic factors in epithelial ovarian carcinoma.
Li L; Liu B; Li X; Yang S; Xiao J; Chen M; Zhang Y; Ma J
Anat Rec (Hoboken); 2009 Apr; 292(4):562-9. PubMed ID: 19226617
[TBL] [Abstract][Full Text] [Related]
26. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas.
Park HR; Min K; Kim HS; Jung WW; Park YK
Pathol Res Pract; 2008; 204(8):575-82. PubMed ID: 18440723
[TBL] [Abstract][Full Text] [Related]
27. [Prognostic significance of VEGF receptors, VEGFR-1 (Flt-1) and VEGFR-2 (KDR/Flk-1) in breast carcinoma].
Dales JP; Garcia S; Bonnier P; Duffaud F; Carpentier S; Djemli A; Ramuz O; Andrac L; Lavaut M; Allasia C; Charpin C
Ann Pathol; 2003 Sep; 23(4):297-305. PubMed ID: 14597894
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of vascular endothelial growth factor expression in human ovarian carcinoma.
Shen GH; Ghazizadeh M; Kawanami O; Shimizu H; Jin E; Araki T; Sugisaki Y
Br J Cancer; 2000 Jul; 83(2):196-203. PubMed ID: 10901370
[TBL] [Abstract][Full Text] [Related]
29. Coexpression of VEGF-C and Cox-2 in human colorectal cancer and its association with lymph node metastasis.
Soumaoro LT; Uetake H; Takagi Y; Iida S; Higuchi T; Yasuno M; Enomoto M; Sugihara K
Dis Colon Rectum; 2006 Mar; 49(3):392-8. PubMed ID: 16474989
[TBL] [Abstract][Full Text] [Related]
30. Vascular endothelial growth factor-C expression and invasive phenotype in ovarian carcinomas.
Ueda M; Hung YC; Terai Y; Kanda K; Kanemura M; Futakuchi H; Yamaguchi H; Akise D; Yasuda M; Ueki M
Clin Cancer Res; 2005 May; 11(9):3225-32. PubMed ID: 15867217
[TBL] [Abstract][Full Text] [Related]
31. Nitric oxide in breast cancer: induction of vascular endothelial growth factor-C and correlation with metastasis and poor prognosis.
Nakamura Y; Yasuoka H; Tsujimoto M; Yoshidome K; Nakahara M; Nakao K; Nakamura M; Kakudo K
Clin Cancer Res; 2006 Feb; 12(4):1201-7. PubMed ID: 16489074
[TBL] [Abstract][Full Text] [Related]
32. Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -D.
Miyata Y; Kanda S; Ohba K; Nomata K; Hayashida Y; Eguchi J; Hayashi T; Kanetake H
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):800-6. PubMed ID: 16467091
[TBL] [Abstract][Full Text] [Related]
33. Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) in human prostate.
Li R; Younes M; Wheeler TM; Scardino P; Ohori M; Frolov A; Ayala G
Prostate; 2004 Feb; 58(2):193-9. PubMed ID: 14716745
[TBL] [Abstract][Full Text] [Related]
34. Vascular endothelial growth factor and its soluble receptor in benign and malignant ovarian tumors.
Artini PG; Ruggiero M; Monteleone P; Carpi A; Cristello F; Cela V; Genazzani AR
Biomed Pharmacother; 2008; 62(6):373-7. PubMed ID: 18037256
[TBL] [Abstract][Full Text] [Related]
35. Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer.
Nakamura Y; Yasuoka H; Tsujimoto M; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
Breast Cancer Res Treat; 2005 May; 91(2):125-32. PubMed ID: 15868440
[TBL] [Abstract][Full Text] [Related]
36. Expression of VEGF-C correlates with a poor prognosis based on analysis of prognostic factors in 73 patients with esophageal squamous cell carcinomas.
Liu P; Chen W; Zhu H; Liu B; Song S; Shen W; Wang F; Tucker S; Zhong B; Wang D
Jpn J Clin Oncol; 2009 Oct; 39(10):644-50. PubMed ID: 19648590
[TBL] [Abstract][Full Text] [Related]
37. Increased expressions of vascular endothelial growth factor (VEGF), VEGF-C and VEGF receptor-3 in prostate cancer tissue are associated with tumor progression.
Yang J; Wu HF; Qian LX; Zhang W; Hua LX; Yu ML; Wang Z; Xu ZQ; Sui YG; Wang XR
Asian J Androl; 2006 Mar; 8(2):169-75. PubMed ID: 16491267
[TBL] [Abstract][Full Text] [Related]
38. Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases.
Yu XM; Lo CY; Chan WF; Lam KY; Leung P; Luk JM
Clin Cancer Res; 2005 Nov; 11(22):8063-9. PubMed ID: 16299237
[TBL] [Abstract][Full Text] [Related]
39. Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms.
Kodama M; Kitadai Y; Tanaka M; Kuwai T; Tanaka S; Oue N; Yasui W; Chayama K
Clin Cancer Res; 2008 Nov; 14(22):7205-14. PubMed ID: 19010837
[TBL] [Abstract][Full Text] [Related]
40. The role of vascular endothelial growth factors and their receptors in malignant melanomas.
Brychtova S; Bezdekova M; Brychta T; Tichy M
Neoplasma; 2008; 55(4):273-9. PubMed ID: 18505336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
